Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / K2 Therapeutics
Entity

K2 Therapeutics

Tracked across 1 events · 6 articles · First seen Jul 20, 2026 · Last active Aug 19, 2026

Sentiment
20
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
2 20
Business
Antengene presents R&D at Evercore Summit
Antengene Corporation Limited, a commercial-stage global biotech company listed on the China — Hong Kong Stock Exchange (SEHK: 6996.HK), presented key research and development highlights at the Evercore 2nd China Biotech Summit. The company disclosed…
Impact: K2 Therapeutics has licensed an Antengene TCE candidate, gaining access to a promising asset.
Jul 20, 2026 · 6 articles
Key Actions (1)
50 Antengene out-licensed drug candidates K2 TherapeuticsAntengene presents R&D at...
ERGEN INTELLIGENCE
Track K2 Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.